Results
1 -
10 of
13
(Click
here to explore results)
- Designing Multi-Target Drugs, Chapter 15 Targeting Protein–Protein Interactions: Dual Inhibitors of Bcl-2 and Bcl-xL. Michael D. Wendt
, 2012
, Pages 243-262
- Anti-fibrotic Drug Discovery, CHAPTER 9 BH3 Mimetic Drugs for Anti-fibrotic Therapy. David Lagares
, 2020
, Pages 235-258
- Fragment-Based Drug Discovery, CHAPTER 6 Fragment-Based Lead Discovery Applied to Protein–Protein Interactions. Roderick E. Hubbard
, 2015
, Pages 126-152
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 4 Identifying and Developing Small Molecule Inhibitors of Protein–Protein Interactions. Rhian S. Holvey, Samuel E. Dalton, Tom D. Heightman, David C. Rees
, 2021
, Pages 111-159
- NMR Spectroscopy for Probing Functional Dynamics at Biological Interfaces, Chapter 15 Structure- and Dynamics-guided Drug Development Using NMR and its Application to Diverse Pharmaceutical Modalities. Koh Takeuchi
, 2022
, Pages 411-448
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 10 α-Helix Mimetics as Inhibitors of Protein–Protein Interactions. A. J. Wilson
, 2021
, Pages 305-335
- Small-molecule Transcription Factor Inhibitors in Oncology, Chapter 5 Small Molecule Inhibitors of NF-κB and Their Therapeutic Potential in Leukaemia. Chris Pepper, Chris Fegan
, 2019
, Pages 125-146
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Subject Index
, 2021
, Pages 336-342
- Anti-fibrotic Drug Discovery, Subject Index
, 2020
, Pages 340-347
- Fragment-Based Drug Discovery, Subject Index
, 2015
, Pages 259-264